Understanding how peptides function helps contextualize why their three-dimensional structure is so critical and why heat disrupts their mechanism of action
A whole month later, my sparse patches gave way to a crescendo of dark baby hairs which concealed my bald patches
Long-Term Safety: What We Know and Don't Know What We Know (From TRIUMPH-4 and TRIUMPH-1) Up to 80 weeks of data: Side effects improve significantly after dose escalation (first 16 weeks hardest) No unexpected safety signals in either trial Dysesthesia doesn't worsen over time (stable) Discontinuation rates stabilize (most who stop do so in first 24 weeks) No deaths attributed to retatrutide in any completed trial TRIUMPH-1 104-week extension shows continued weight loss without new safety signals What We Don't Know Yet Longer-term questions (need 25+ years data): Does dysesthesia resolve completely if medication stopped
GLP-1 and its analogs have also been found to inhibit cellular migration and other essential facets of inflammation, thus mitigating atherosclerosis
References: [1] FDA, Vyleesi, June 2919 [2] Mayo Clinic, Vyleesi, January 2026 [3] National Library of Medicine, Bremelanotide, Dhillon, S., Keam, S.J., September, 2019
)
)
